Skip to content

CETIS-I (CEra Traction Improves Spine-I)

A Single-center, Open-label, Randomized, Parallel-group, Standard Therapy Controlled, Equivalence Clinical Trials to Evaluate the Efficacy and Safety of Structural Changes in the Spine to Determine the Traction Effect of an Investigational Device, Ceragem Master V6 (CGM MB-1701) Use in Patients With Lumber Disc Herniation & Degenerative Spinal Stenosis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05549596
Enrollment
60
Registered
2022-09-22
Start date
2023-01-03
Completion date
2024-05-22
Last updated
2026-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Spinal Stenosis, Lumbar Disc Herniation, Spine Traction

Brief summary

In this clinical trial, equivalence is evaluated by exploratory comparison of changes in X-Ray lesions with test group (Cerazem Master V6) and control group (physical therapy) in patients with intervertebral disc herniation and degenerative stenosis.

Detailed description

The efficacy and safety evaluation are conducted before and after the application of the test device. The investigator shall apply an investigational device once when visiting a suitable subject for one day (Arm;Traction treatment) or standard physical therapy including temperature application and traction(Arm;Physical Therapy)

Interventions

DEVICECeragem Master V6 Traction

Ceragem Master V6 Traction for L2\~L3

DEVICEPhysical therapy with standard traction device

Physical therapy with standard traction device

Sponsors

Ceragem Clinical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject who has been diagnosed with intervertebral disc herniation or degenerative stenosis (a person who has been diagnosed in the past or has been diagnosed upon obtaining consent) * Adult men and women over 19 years of age * Body mass index (BMI) 18.5 over to less than 30

Exclusion criteria

* Subject with fibromyalgia, dystonia, and epilepsy * Subject with sensory impairment * Subject with physical irritation-induced skin lesions such as fever and compression (dermatosis, compression urticaria, choline urticaria, fever urticaria, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Anterior and posterior distance changes of L2-S1 intervertebral discImmediately after applicationAnterior and posterior distance changes of L2-S1 intervertebral disc are evaluated through X-Ray immediately after application of medical device compared to baseline

Secondary

MeasureTime frameDescription
Ratio of L2-S1 Anterior/posterior intervertebral distanceImmediately after applicationRatio of L2-S1 Anterior/posterior intervertebral distance evaluated by X-Ray immediately after application of medical device compared to baseline (A/P ratio)
Changes in lower extremity radiation painImmediately after applicationChanges in lower extremity radiation pain evaluated through VAS immediately after application of medical device compared to baseline
Changes in the range of waist movementImmediately after applicationChanges in the range of waist movement evaluated by the Schober test immediately after one application of medical device compare to baseline
Change in the angle evaluated by the SLR testImmediately after applicationChange in the angle evaluated by the Straight Leg Rasing test (SLR test) modified immediately after the application of the medical device compared to the baseline

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORYong Soon Yoon

Presbyterian Medical Cente

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026